Clinical Trials Directory

Trials / Completed

CompletedNCT02723188

Modulation of Fear Extinction Processes Using Transcranial Electrical Stimulation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Tel Aviv University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to examine the effects of transcranial electrical stimulation on processes associated with fear extinction in healthy humans.

Detailed description

Research links the processes of fear conditioning and extinction to the treatment of anxiety and stress-related disorders. Moreover, considerable translational research examines the neural correlates of these processes. However, virtually no research in humans manipulates neural correlates of these processes, which limits basic-clinical integration. The present study aimed to use transcranial electrical stimulation (tES) to modulate processes associated with fear extinction in order to assess the potential utility of tES in enhancing exposure-based treatment. To this end, healthy participants underwent a three-day fear conditioning and extinction paradigm. Participants were randomly assigned into 3 groups, differing in terms of tES applied during the extinction learning phase (Day 2) and targeting the medial prefrontal cortex: 1) direct current (DC) stimulation, aimed at enhancing extinction learning; 2) alternate current (AC) stimulation, aimed at interfering with reconsolidation of the fear memory activated during the extinction phase; and 3) sham stimulation. The outcome measures (outlined next) involve the assessment of extinction recall during a test phase (Day 3). Successful modulation of extinction learning by tES would be reflected in enhanced extinction recall.

Conditions

Interventions

TypeNameDescription
DEVICESham stimulation (1.5 milliampere,30 seconds)
DEVICEDC stimulation (1.5 milliampere, 20 minutes)
DEVICEAC stimulation (1.5 milliampere,1.5 Hertz frequency)

Timeline

Start date
2014-09-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2016-03-30
Last updated
2017-06-14
Results posted
2017-06-14

Source: ClinicalTrials.gov record NCT02723188. Inclusion in this directory is not an endorsement.